ITA | ENG
  • Equistasi® - The device

    The Equistasi® project stems from advanced technical-scientific research that started back in 1996, based on experimental applications in the fields of theoretical and applied nanotechnology.

    Equistasi® is a wearable and innovative medical device, approved by the Ministry of Health on 05-08-2010 with CNN product code number 342575 and COP product code number 342577. It is based on vibrational technology: it self-generates focal mechanical vibrations at a non-constant frequency of about 9000 Hz, within the limits imposed by Legislative Decree 81/08.

    Equistasi® has characteristics that make it, to date, a highly innovative tool:
    a) It’s wearable: this device is applied like you would a regular bandage strip during daily motor activities with total independence or during the rehabilitation treatment carried out by a physiotherapist or professional in the sector.
    b) It’s lightweight: this device is 1×2 cm in size and has a feather-light weight of only 0.17 grams.
    c) It’s multi-applicable: this device can be reused several times and in different areas for different issues, depending on the instructions of the therapist or doctor.
    d) It will not expire: other than general wear, this device will never expire.

    Equistasi® is composed exclusively of applied nanotechnology fibres and does not contain any pharmacological elements. It provides support for the patient’s rehabilitative therapy.

    Focal mechanical vibration applied on the affected muscular areas interacts with the mechanoreceptors, the Golgi tendon organs and the neuromuscular spindles. The stimuli generated by the vibrations transmit the information to the central nervous system. Stimulated by the vibrations, the higher motor centres improve the proprioceptive information that underlies motor control.

    For these reasons, the application of Equistasi® proves to be an innovative and particularly interesting rehabilitative therapy.
    Physiotherapists play a fundamental role in innovative rehabilitation; they must possess multidisciplinary knowledge in biomechanics, anatomy, physiology and neurophysiology and must be ready to predict the effects of the interaction between the Equistasi® device and the anatomical areas involved in the process.

  • Equistasi® - Composition

    Equistasi® is composed exclusively of applied nanotechnology fibres and does not contain any pharmacological elements. It provides support for the patient’s rehabilitative therapy.

  • Equistasi® - Effects of the vibrations

    The Equistasi® device was conceived and designed by following the guidelines of some clinical studies and significant scientific publications:

    • 1963 – Prof. R. Bianconi, head professor of Human Physiology at the Catholic University of Rome, showed that low-amplitude FV vibrations can potently and selectively stimulate some types of nerve receptors involved in motor control.
    • 1996 – Necking et al. showed that, to be effective and certainly not harmful, a vibratory stimulus must be localised on single muscle groups, have limited wave amplitude and not impose length variations greater than 0.12 mm on the muscles.

    Based on what has been said so far, Equistasi® meets three fundamental principles:

    1. Focal Application: Equistasi® is 1 sq cm in size.
    2. Reduced Amplitude: the wave amplitude generated by Equistasi® is so small that it can be traced but cannot be calculated using normal measurement methods.
    3. Adequate Strength: Equistasi® uses a stimulus based on strength intensity not exceeding 0.8 N, generating a maximum length variation of 0.002 mm.

    Equistasi® is composed of fibres that are sensitive to the smallest thermal variations, which the product transforms into mechanical energy by self-generating a focal vibration.

    Focal mechanical vibration applied on the affected muscular areas interacts with the mechanoreceptors, the Golgi tendon organs, and the neuromuscular spindles. The stimuli generated by the vibrations transmit the information to the central nervous system; stimulated by the vibrations, the higher motor centres improve the proprioceptive information that underlies motor control. Equistasi® does not expire, although wear and tear will affect the entire device.

  • Equistasi® – Applications

    • Equistasi and Parkinson’s disease

    One of the most serious degenerative consequences of Parkinson’s disease is postural instability. It affects the quality of the patient’s daily life in serious ways and varying degrees, causing frequent falls and fractures that require hospitalisation, invasive treatments and – in the most critical cases – surgical interventions.

    Important clinical studies show that the Equistasi® device, applied on the skin as a rehabilitative therapy aid for patients affected by this disease, allows the stimulation of the proprioceptive system, helping patients reacquire their body perception and perform more correct movements, reducing the rate of falls and improving general balance.

    Visit the dedicated page. The complete study can be consulted at this link.

    • Equistasi and Multiple Sclerosis

    Important clinical studies show that patients treated with Equistasi® as a support to regular medical therapy show progress in walking, during the first step, in the average step length, in the simultaneous double support on the right and on the left, and overall less fatigue to complete these actions.

    Visit the dedicated page. The complete study is available in the scientific journal Restorative Neurology and Neuroscience and at this link.

    • Equistasi and Cerebellar Ataxia or Friedreich’s Ataxia

    In combination with a cycle of non-invasive rehabilitation therapies, continuous use of the Equistasi® device could guarantee improvements in limb motor coordination, general gait, and language flow of patients affected by hereditary Cerebellar Ataxia, such as Friedreich’s.

    Visit the dedicated page. A complete study is available in the scientific journal Neurological Sciences and at this link.

  • Equistasi® – The effects

    The effects of the focal mechanical vibrations produced by the medical device Equistasi® are perceivable on average within twenty minutes after the first application. They can be classified into three categories:

    • Neuromuscular rehabilitative effects

    These effects include improved posture, balance, general gait, and reduced muscular hypertonias and hypotonias.

    • Orthopaedic rehabilitative effects

    TThese effects include improved joint movements and antalgic action, shorter postoperative recovery time, and reduced edemas/lympho-edemas.

    • Increased muscle-posture performance effects

    These effects include improved athletic performance and rationalisation of energies.